Roche at ECCO 2019
Mar 08, 2019 | Gastro immunologyMar 08, 2019 | Gastro immunology
This study evaluated the correlation between histological, endoscopic and clinical disease activity assessments at the end of induction using data from the open-label cohort of the HICKORY trial.
Mar 08, 2019 | Gastro immunology
ECCO poster 2019: Responder definitions for the Ulcerative Colitis Patient-Reported Outcomes Signs and Symptoms (UC-PRO/SS) tool using patients with Ulcerative Colitis treated with etrolizumabMar 08, 2019 | Gastro immunology
The Ulcerative Colitis Patient-Reported Outcomes Signs and Symptoms (UC-PRO/SS) diary is the first PRO tool to undergo a rigorous development process outlined by health authorities, with input from patients and clinical experts. This study proposes responder definitions for the UC-PRO/SS using patients treated with etrolizumab from the Phase 3 open-label induction cohorts of HICKORY and LAUREL.